Putnam Investments’s Evolent Health EVH Stock Holding History

Putnam Investments’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$16.5M	Buy	500,779 +91,820	+22%	+$2.6M	0.02%	255
2023 Q3	$11.1M	Buy	408,959 +44,845	+12%	+$1.25M	0.02%	290
2023 Q2	$11M	Buy	364,114 +59,383	+19%	+$1.92M	0.02%	292
2023 Q1	$9.89M	Buy	304,731 +139,615	+85%	+$4.42M	0.02%	314
2022 Q4	$4.64M	Buy	165,116 +98,005	+146%	+$2.81M	0.01%	457
2022 Q3	$2.41M	Buy	+67,111	New	+$2.36M	﹤0.01%	696
2017 Q3	–	Sell	-78,611	Closed	-$1.99M	–	1136
2017 Q2	$1.99M	Sell	78,611 -157,469	-67%	-$3.79M	﹤0.01%	789
2017 Q1	$5.26M	Buy	236,080 +64,731	+38%	+$1.24M	0.01%	564
2016 Q4	$2.54M	Buy	+171,349	New	+$3.38M	0.01%	789

Other funds holding EVH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Putnam Investments's EVH Position: Q4 2023 in Review

Putnam Investments increased its Evolent Health (EVH) stake by 22% in Q4 2023, buying an estimated $2.6M and bringing the position to 500,779 shares worth $16.5M. The position accounts for 0.02% of the portfolio, ranked #255.

Putnam Investments first reported a position in EVH in Q4 2016 and has held it in 9 quarters since. 234 funds tracked by Wall St. Rank hold EVH as of Q4 2023.

Putnam Investments held 500,779 shares of Evolent Health worth $16.5M as of Q4 2023.
Putnam Investments bought 91,820 Evolent Health shares in Q4 2023, an estimated $2.6M.
Evolent Health made up 0.02% of Putnam Investments's portfolio in Q4 2023, its #255 holding.
Putnam Investments first reported a position in Evolent Health in Q4 2016 and has held it in 9 quarters since.
234 funds tracked by Wall St. Rank held Evolent Health as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.